ARCHIVES

Low-Dose IFN Not Effective Against Melanoma, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI

October 10, 1997

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011